You may have heard that GLP-1 medications are only for people at the very top of the weight charts. That belief is common, and it is also incomplete, because a single number was never meant to tell the whole story.
If you have spent twenty years cycling through diets that worked for a while and then quietly unraveled, you already know your body is more complicated than a number on a scale. This article is here to explain, in plain language, the fuller picture an independent provider actually looks at before recommending anything. It is educational only and is not medical advice.
Why one number was never the whole story
Body Mass Index (BMI) is a quick screening tool. It divides your weight by your height and sorts the result into categories. It is useful for looking at large groups of people, but it has real limits for any single person. BMI does not know the difference between muscle and fat, it does not know where your body stores fat, and it does not measure what is happening in your blood [1][2].
That is why guidelines from major medical bodies stopped treating BMI as a solo gatekeeper years ago. The American Medical Association has openly acknowledged that BMI is an imperfect measure that should be used alongside other information, not by itself [2]. In other words, the idea that one BMI number decides everything is out of step with how thoughtful care actually works.
What a provider looks at alongside BMI
When an independent, licensed provider reviews someone's metabolic health, they are usually assembling several pieces at once. No single piece is the verdict. Together, they form a picture.
Waist circumference: where fat sits matters
Fat stored deep around the abdomen (visceral fat) behaves differently than fat elsewhere. A larger waist measurement is associated with higher cardiometabolic risk, even in people whose BMI looks similar to someone else's. Health authorities commonly flag increased risk at a waist above about 35 inches (88 cm) for women and 40 inches (102 cm) for men [1][3]. This is one reason two people with the same BMI can have very different health pictures.
Blood sugar and insulin markers
Providers often review fasting glucose and hemoglobin A1c, a blood test that reflects average blood sugar over roughly three months. The American Diabetes Association describes prediabetes as an A1c of 5.7 to 6.4 percent, with 6.5 percent or higher in the diabetes range on repeat testing [4]. These numbers help a provider understand how the body is handling sugar long before anyone would call it a crisis.
Blood pressure, cholesterol, and triglycerides
A cluster of findings (larger waist, higher blood pressure, higher triglycerides, lower HDL cholesterol, and higher blood sugar) is described medically as metabolic syndrome. Having several of these together signals meaningfully higher risk for heart disease and type 2 diabetes [3]. A provider is looking for patterns across these markers, not reacting to any one line on a lab sheet.
inches · marker = Risk threshold (women)
Source: [4] American Diabetes Association: Understanding A1C Diagnosis
How these pieces fit together
Imagine two people who weigh the same. One has a smaller waist, normal blood sugar, and healthy triglycerides. The other has a larger waist, an A1c edging into the prediabetes range, and elevated blood pressure. Their BMI might be identical, but their metabolic stories are not. A careful provider reads the second person's picture very differently.
This is why hearing that your numbers are "creeping up" during a rushed physical can feel so unsatisfying. "Creeping up" is actually the exact moment when the fuller picture matters most, because it is where patterns start to form and where a real conversation can begin.
Source: [1] Assessing Your Weight and Health Risk, [3] Grundy SM et al., Diagnosis and Management of the Metabolic Syndrome: AHA/NHLBI Scientific Statement, [4] American Diabetes Association: Understanding A1C Diagnosis
Where GLP-1 medications enter the conversation
GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally releases after you eat. It helps signal fullness and plays a role in how the body manages blood sugar. Medications in the GLP-1 class (such as semaglutide) and dual-action medications (such as tirzepatide, which also acts on the GIP receptor) work with these hormone pathways [5][6].
Here is the important part: whether any medication is appropriate is a clinical decision made by an independent, licensed provider after reviewing your full history, your labs, and your goals. Eligibility is never decided by a single BMI number pulled out of context, and a prescription is never guaranteed. The provider weighs benefits, your other health conditions, and safety considerations together.
Common, well-documented side effects of GLP-1 medications are largely gastrointestinal, such as nausea, vomiting, diarrhea, and constipation, especially early on [5][6]. There are also important safety warnings, including a boxed warning related to a risk of thyroid C-cell tumors seen in animal studies, and these medications are not appropriate for everyone [5]. This is exactly the kind of honest, individual conversation a provider is meant to have with you, rather than something you should sort out alone from stories you have read online.
Being taken seriously is part of good care
Decades of yo-yo dieting are not a personal failure, and "eat less, move more" ignores how much biology, hormones, and metabolism shape hunger and weight regulation. If knees and a lower back ache, being told to simply exercise more is not just unhelpful, it can feel dismissive of a real barrier.
A good clinical review starts from a different place. It asks what your body is actually doing, looks at the markers together, and treats you as a whole person with a long history worth understanding. That is the standard you deserve, whether or not any medication ever becomes part of the plan.
Where Velri fits
Velri is a technology and coordination company, not a medical provider. Velri does not practice medicine and employs no physicians. What Velri does is help organize the steps that often feel scattered and intimidating.
That coordination can include helping arrange lab work so the fuller metabolic picture (things like A1c, lipids, and other markers) is available, connecting you with an independent, physician-led Provider Group for a visit where a licensed provider reviews your history and results, and, if a provider decides a prescription is appropriate for you, coordinating with an independent, licensed pharmacy. Coverage currently starts in Nevada, with more states rolling out over time.
Whether any treatment, including a GLP-1 medication, is right for you is always determined by an independent licensed provider, and a prescription is never guaranteed. Some medications discussed in this space may be compounded. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
This article is educational and is not medical advice. For guidance about your own health, please talk with a licensed healthcare provider.
